Jared Whitlock

Reporter

Email: jwhitlock@sdbj.com
Phone: 858-634-4636 Extension: 3130

Recent Stories

Q3: Neurocrine Reports Rising Drug Sales

San Diego biotech Neurocrine reported $151.8 million in quarter three revenue, a 150 percent year-over-year increase.

MEI Pharma Receives $10M Up Front in Licensing Deal

San Diego-based MEI Pharma licensed its drug candidate to Japanese company Kyowa Hakko Kirin, receiving $10 million up front, with an additional $87.5 million in development milestones and sales royalties possible if the drug wins approval in Japan.

Fiscal Policy Now On Front Burner at Scripps

HEALTH: Aim Is to Rely Less on NIH and More on Its Programs

Scripps Research’s latest annual statement shows a higher operating deficit than years past, but management predicted stronger financials amid a shift in direction.

Tease photo

ResMed to Buy MatrixCare for $750M

Medical device company ResMed looks to expand its software-as-a-service business through a recently announced acquisition.

Illumina Aims to Increase Sequencing Dominance with $1.2B Planned Acquisition

Illumina is poised to acquire niche competitor Pacific Biosciences for $1.2 billion, a deal analysts say would fortify Illumina’s dominance in genomic sequencing.

Halozyme Licenses Drug Delivery Technology to Roche

Halozyme Therapeutics is expanding the reach of its platform that delivers drugs under the skin, intended to do away with lengthy infusions.

Tease photo

Illumina to Buy Pacific Biosciences for $1.2 Billion

Illumina is poised to acquire Pacific Biosciences for $1.2 billion, a deal Illumina says will pave the way for a more complete view of the genome.

AMN Healthcare’s Stock Rises on Strong Q3 Results

AMN Healthcare reported jumps in revenue, gross profit and other metrics in quarter three results, boosting the company’s stock.

Halozyme Licenses Drug-Delivery Technology to Roche for New Targets

Halozyme Therapeutics is expanding the reach of its platform that delivers drugs under the skin, intended to do away with lengthy infusions.

San Ysidro Health Receives $131K Dental Grant

The Delta Dental Community Care Foundation recently gave a $131,483 grant to San Ysidro Health to upgrade dental work spaces and for an X-ray system.

Acadia’s CFO to Depart

Todd Young, the chief financial officer of Acadia Pharmaceuticals, recently joined another company.

Device Cos. Flourish as Technology, Talent and Data Are Powering Growth

DEVICES: Region Also Has Strong Exec Bullpen, Partnership Possibilities

About a decade ago, Dexcom executives explored a wild idea: a constant reading of glucose levels beamed to a smartphone.

Tease photo

Smaller Medical Device Cos. Also in Position to Deliver

MEDTECH: Ra Medical Raises $66.3 Million In September IPO

While the big dogs of San Diego’s medical device scene are putting up strong numbers, the region’s smaller players in the space can’t be overlooked.

Tease photo

New CEO Expected to Bring Fresh Perspective to NuVasive

San Diego-based NuVasive recently tapped a new CEO, a move analysts say looks to bring fresh perspective to an expanding company that’s nonetheless stumbled on execution and has been an acquisition target.

Tease photo

Q1: ResMed’s Net Income Rises 23%

San Diego medical device company ResMed posted revenue of $588.3 million in quarter one results, a 12 percent year-over-year increase.

UC Workers Begin 3-Day Strike at Medical Centers

Patient technical care workers and other union employees across the state, including in San Diego, on Tuesday started a three-day walkout aimed at UC Medical Centers.

Q3: Illumina Tops Earnings Estimate

Illumina reported adjusted quarter three earnings per share of $1.52, or $0.26 better than analysts’ expectation.

Qpex Biopharma Debuts with $33M Round

Qpex Biopharma, in the business of antibiotics to combat antimicrobial resistance, surfaced Oct. 22 with a $33 million Series A round and a contract worth up to $132 million.

Ionis, Roche Partner on Macular Degeneration Drug

Swiss drug giant Roche and Carlsbad’s Ionis Pharmaceuticals seem increasingly enamored with one another.

Tease photo

NIH Grant Gives Salk Researcher Backing in ‘High-Risk’ Endeavor

Janelle Ayres, an associate professor with Salk Institute for Biological Studies who is taking on challenges posed by infectious disease and antibiotic resistance, earlier this month landed a $3.5 million National Institutes of Health grant.

Study: Reflexion's Virtual Physical Therapy Reduces Costs

Virtual physical therapy from San Diego-based Reflexion Health was effective as traditional therapy while saving money, according to a first-of-its-kind clinical trial conducted by Duke Clinical Research Institute.

Ionis, Roche Strengthen Ties with Deal Worth Up to $759M

Swiss drug giant Roche and Carlsbad’s Ionis Pharmaceuticals seem increasingly enamored with one another.

New Palomar CEO Takes on Financial, Medical And Staffing Challenges

The word “interim” in a job title implies caretaker. Not to Diane Hansen, evidently.

Tease photo

Xenco Medical CEO Named to California Workforce Development Board

Jason Haider, the CEO of San Diego-based Xenco Medical, has been appointed by Gov. Jerry Brown to the California Workforce Development Board.

Ionis Gets Good News With FDA Approval

Ionis Pharmaceuticals’ drug for a rare genetic disorder recently gained regulatory approval, a relief to investors worried about a denial, and pitting the company against Alnylam Pharmaceuticals.

Tease photo

MappBio Wins Contract To Combat Viruses

San Diego’s MappBio recently received a $14.8 million contract to advance a treatment for Sudan virus.

AMN Healthcare Says HQ Will Remain Local

San Diego’s AMN Healthcare is not relocating to Dallas, ending speculation raised by the CEO’s new home and twin datelines.

Tease photo

Scripps Research Adds Board of Overseers

Scripps Research added a 21-member Board of Overseers with big names from across San Diego life sciences as the organization broadens its scope, it was recently announced.

UC San Diego to Open New Rancho Bernardo Facility

UC San Diego Health on Oct. 15 will open a 57,000-square-foot Rancho Bernardo center with offerings spanning primary care, urgent care and behavioral health.

Institutes Take Cues From Business for Funding

FINANCE: Quest for Private Money Brings New Models, Partnerships

UC San Diego’s drug research arm in recent years took a new tack with investors and pharmaceuticals: Tell us what we’re doing wrong.

Tease photo

Sharp Grossmont Hospital’s Burr Heart & Vascular Center Opens

Burr Heart & Vascular Center at Sharp Grossmont Hospital – per Sharp the only dedicated cardiovascular center in East County -- recently began treating patients.

With Drug Approval, Ionis Set to Compete with Alnylam

The U.S. Food and Drug Administration on Oct. 5 approved Ionis Pharmaceuticals’ drug for a potentially fatal genetic disorder, pitting the company against Alnylam Pharmaceuticals.

Biotechs Among Most Impacted by Gender Law

LEGAL: Women Often Bypassed On Local Life Science Boards

The San Diego biotech industry stands to be particularly affected by a recently signed bill requiring California public companies to have at least one woman on their board by the end of 2019.

Tease photo

Medtechs Lead Life Science Stock Gains for Third Quarter

Medtechs led the way in stocks of public life science companies in San Diego during the third quarter.

Tease photo

MappBio Awarded $14.8M Contract for Sudan Virus Therapy

San Diego’s MappBio received a $14.8 million contract to advance a treatment for Sudan virus.

Biotechs Among Most Impacted by Law Requiring Women on Boards

LEGAL: Dearth of Women on Local Life Science Boards

The San Diego biotech industry stands to be particularly affected by a recently signed bill requiring California public companies to have at least one woman on their board by the end of 2019.

Frances Arnold, an Illumina Board Member, Shares Nobel Prize

The board director of San Diego life sciences giant Illumina and professor at Caltech shared in the Nobel Prize for Chemistry.

Tease photo

Acadia and FDA Confident in Parkinson’s Psychosis Drug

Acadia Pharmaceuticals is flying higher after the U.S. Food and Drug Administration reaffirmed its drug in uncharacteristically public fashion.

VelosBio Lands $58M Round

VelosBio, a San Diego-based firm developing cancer drugs, received a $58 million Series A round, investor Arix Bioscience recently announced.

Careful Approach to CBD Sales Paying Off

CANNABIS: Products Tested; Co. Also Working on New Drug

CV Sciences has emerged as a major player of a burgeoning corner of the cannabis industry: hemp-derived cannabidiol.

Tease photo

Ra Medical Raises $66.3M in Trading Debut

Carlsbad’s Ra Medical Systems became a public company on Sept. 27, raising $66.3 million.

Life Sciences Reporter's Notebook: Life Sciences Loads Up on VC Dollars

In San Diego, life sciences dominates in early-stage investment. Looking at 2017 through this September — a 19-month period — San Diego-based life sciences companies pulled in $2.73 billion in venture capital, according to a recently released snapshot from JLL research. That represented 44.8 percent of venture capital in San Diego, more than the next three categories combined.

Tease photo

Tocagen Hires Head of Commercial Role

Tocagen, a San Diego company behind a cancer therapy that’s in a final-stage trial, is building up commercial operations.

Rady Children’s Launches Medi-Cal Pilot for Genetic Testing in Newborns

Rady Children’s Hospital recently announced its lead role in a state pilot program that will expand genome sequencing for critically ill newborns.

Epic Aims to ‘Revolutionize Cancer Care’

MEDICINE: Extending Lives, Cutting Waste Are Part of Goals

Epic Sciences’ pitch: greater certainty.

Tease photo

Vital Therapies Lays Off 83 Employees After Clinical Trial

After halting a treatment for acute liver failure, Vital laid off 83 employees, according to a state notice.

FDA Fast-Track Designation for Cidara Therapeutics

San Diego-based Cidara Therapeutics gained fast-track status from the U.S. Food and Drug Administration for its lead drug candidate aimed at preventing invasive fungal infections, the company announced Sept. 25.

Medical System Wants To Be Housing Provider

HEALTH: Plans Aim to Cut Congestion, Fund Infrastructure

Long a provider of housing for university students, UC San Diego is now pushing for dwellings for employees of its medical system.

Tease photo

Equillium Prepares $86M IPO

La Jolla-based Equillium intends to raise $86 million through an initial public offering, according to recently filed U.S. Securities and Exchange Commission paperwork.

La Jolla Vein Care Adds Space

La Jolla Vein Care – which treats vein disease and disorders – recently doubled its clinic space.